Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors.
about
Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell linesThe concept of immune surveillance against tumors. The first theoriesTowards improved cancer diagnosis and prognosis using analysis of gene expression data and computer aided imaging.Role of HER2 gene overexpression in breast carcinoma.HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.Anti-HER2 vaccines: new prospects for breast cancer therapyGlobal gene expression profiling in interleukin-12-induced activation of CD8(+) cytotoxic T lymphocytes against mouse mammary CarcinomaThe epidermal growth factor receptor family in breast cancer.Testing for HER2 in Breast Cancer: A Continuing Evolution.The significance of immunohistochemistry in the diagnosis and therapy of neoplasms.Hypoxia-induced pathways in breast cancer.Prognostic and predictive value of HER2/neu oncogene in breast cancer.Synthetic peptides as cancer vaccines.Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer.IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest in breast carcinoma.Targeted therapy in breast cancer: the HER-2/neu gene and protein.Prognostic significance of immunoreactive neutrophil elastase in human breast cancer: long-term follow-up results in 313 patientsStudy of the biological and prognostic significance of the antigen CaMBr8 on breast carcinoma.Prognosis based on primary breast carcinoma instead of pathological nodal status.Potential prognostic value in human breast cancer of cytosolic Nme1 protein detection using an original hen specific antibodyVariation of hormonal receptor, pS2, c-erbB-2 and GSTpi contents in breast carcinomas under tamoxifen: a study of 74 cases.Inflammatory infiltrate in invasive lobular and ductal carcinoma of the breast.Laminin activates the p185HER2 oncoprotein and mediates growth inhibition of breast carcinoma cellspS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patientsThe relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancerIdentification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines.Moderate immunohistochemical expression of HER-2 (2+) without HER-2 gene amplification is a negative prognostic factor in early breast cancer.c-erbB2/neu gene and chromosome 17 analysis in breast cancer by FISH on archival cytological fine-needle aspirates.The clinical significance of tumor-infiltrating lymphocytes and microscopic satellites in acral melanoma in a korean population.An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer.Role of hormonal risk factors in HER2-positive breast carcinomas.Isolation and characterisation of a human anti-idiotypic scFv used as a surrogate tumour antigen to elicit an anti-HER-2/neu humoral response in mice.Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines.Angiogenesis and inflammation in invasive carcinoma of the breast.Synthetic phosphopeptide immunogens yield activation-specific antibodies to the c-erbB-2 receptor.HER2 as a target for breast cancer therapy.The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review.An algorithm for direct causal learning of influences on patient outcomes.Prognostic significance of biologic markers in node-negative breast cancer patients: a prospective study.
P2860
Q24650717-6E98D3A9-908B-45A1-887A-387E7CAA80E2Q28073937-38C00F60-4DA0-4BB7-AAC1-9B49BC10EAA3Q33459037-1BE1D5E6-1EDD-4F4B-834C-075C0140DFBAQ33810080-88220F47-3B17-4510-8478-E45009439321Q33968465-A7C8DC1F-6ADF-474D-AE0E-9AC7881CEE1CQ34105959-8677B5AB-693C-4EE3-84E6-8D4C97E13E53Q34245822-494FED57-7EC5-4CF4-8DCA-E1CE2D3DBA05Q34363400-06BCDC46-25FA-41BC-A715-1683530F4FBBQ34424285-B3F5A374-E33F-40D5-873B-9B800B295B00Q34602545-E2950893-07DB-4C70-B813-4F838B95D951Q34872665-3CB57C84-2D0F-49A0-91AE-ABD8D32D9E9BQ34954864-DC1B05B2-25DD-49F2-8959-84D95947B1BFQ34972916-A1555D9B-5E76-4C94-AC3B-F165601F3D8AQ35000651-424BDB74-8C41-46C4-8280-CFA55A7647BEQ35588768-75CB6202-1D72-41A7-8DA5-52D5628C6838Q35648508-8131BFF8-6873-495D-8673-5CC1AC9C4D7AQ35721214-FF183AB1-4BB4-40C4-98F1-13B51F0614E9Q35993619-B56457BE-BF05-48D1-855D-AF1751D26E8BQ36079769-86EE1C3C-3179-4363-807D-BA09699C29F2Q36134621-0B330909-08E6-4353-BBAE-329D5A29D819Q36134697-40BAB46C-1CA8-4CB5-8ACD-416F68BA780EQ36136011-84B10F1A-6512-48B3-A839-419180375EDAQ36136193-C466367D-E97A-4446-8E74-F447DA975316Q36141002-429DC038-BEAB-4811-903A-EFFA98B88855Q36186338-5B8E16AF-CFB7-48B4-B9BE-C71608883CEFQ36364998-CE9CC1B8-6ECD-4C88-BFED-CC9CE045715CQ36405652-815BD7C5-A0F1-4E45-8446-249E94C449A3Q36617940-41AFDEEA-21E2-497C-9608-A2FA6D5D7A07Q36640550-4201DA73-ED4F-4B31-A9FC-8877A74A79A7Q36643153-E16B1261-D71E-4D44-A2C1-B3AA27C3337EQ36646681-C65AC3F6-1458-4C3C-B92A-70125DAD322EQ36694110-F0825BD3-49EC-425A-8EE3-68A12602DCB5Q36739364-DD05FC57-CD1A-4E36-851A-467842796C2FQ37131308-96E231F2-5524-4D7A-9157-48A36B7BC1ADQ37210559-323ED1C0-9A0D-4A21-B926-7F37818B1210Q37280359-5BF16FE7-23C1-47EE-96B3-9488093D53E9Q37705396-92EC218E-BB2F-47EE-980B-FAE72FD94616Q37944938-645DEBDD-7402-4005-8588-EC6C28638691Q38864228-926A5F65-5BBE-43E1-9A75-80CD8B4FDA3BQ40735449-62CCAD10-FB6D-428D-B3CC-59734139003C
P2860
Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Prognostic significance of HER ...... p to other prognostic factors.
@en
type
label
Prognostic significance of HER ...... p to other prognostic factors.
@en
prefLabel
Prognostic significance of HER ...... p to other prognostic factors.
@en
P2093
P2860
P356
P1476
Prognostic significance of HER ...... p to other prognostic factors.
@en
P2093
G Della Porta
M A Pierotti
M I Colnaghi
M T Baldini
N Cascinelli
R Bufalino
S Andreola
P2860
P356
10.1002/IJC.2910490109
P577
1991-08-01T00:00:00Z